Chronic Immune Thrombocytopenia Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 0.54% during the forecast period (2022-2029).
TNF inhibitors, also called TNF blockers, biologic therapies, or anti-TNF drugs, help stop inflammation. They treat Rheumatoid Arthritis (RA), juvenile arthritis, psoriatic arthritis, plaque psoriasis, ankylosing spondylitis, Ulcerative Colitis (UC), and Crohn’s disease.
To Download free sample @ Click Here
The growing incidence of inflammatory conditions will drive marketplace increase.
The tumor necrosis issue inhibitor capsules market increase is driven by using growing incidences of numerous inflammatory situations along with Rheumatoid Arthritis (RA), psoriasis, ankylosing spondylitis, Ulcerative Colitis (UC), Crohn’s disorder, and others.
For instance, in line with NIH, one of the most important changes that arise throughout aging is the dysregulation of the immune response, main to a chronic systemic inflammatory country. Therefore, the developing geriatric populace is fueling the worldwide marketplace; for example, Department of Economics and Social Affairs United States facts indicates that in 2020 the quantity of people aged 65 and over changed into around 272mil that’s expected to attain 1.5bil by using 2050.
Furthermore, according to the World Psoriasis Day consortium, around one hundred twenty five million human beings international, or 2 to a few percent of the full populace, have psoriasis; as consistent with the University of Washington Medicine, 8% of the total healthy white Americans and a couple of-three% percent of the overall healthful African Americans accounting for 300k Americans suffer ankylosing spondylitis. According to the Global RA Network, over 350 million humans can have arthritis globally in 2021.
In addition, consistent with NIH, in 2035, as compared to 2020, we expected a 2.5-fold upward thrust in incidence for Iran with 69 thousand instances, a 2.3-fold increment for North Africa and the Middle East with 220 thousand cases, quadrupling of the superiority for India with 2.2 million cases, a 1.Five-fold growth for East Asia region with four.5 million cases, and a 1.6-fold elevation in occurrence for high‐earnings Asia‐Pacific and Southeast Asia regions with 183 and 199 thousand cases respectively.
Moreover, the studies conducted with the aid of Crohn’s & Colitis UK in 2022 suggests that 1 in each 123 people in the UK has both Crohn’s disorder or ulcerative colitis. Also, quantities to a total of nearly 1/2 one million human beings inside the UK residing with IBD. In addition, an increasing number of biosimilars coming into the market is possibly to growth the affordability and power the intake of TNF inhibitors, which in flip is projected to fuel the marketplace globally all through the forecast period.
By Drug Type
- Adalimumab (Humira)
- Certolizumab (Cimzia)
- Etanercept (Enbrel)
- Golimumab (Simponi)
- Crohn’s Disease
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Plaque Psoriasis
By End User
- Hospital And Clinics
Some of the major players in the tumor necrosis factor inhibitor drugs market are Amgen Inc, AbbVie Inc, Pfizer, Inc, Samsung Bioepis Co., Ltd., Sanofi, Novartis International AG, Johnson & Johnson Services, Merck & co., and others. The company has a vast portfolio in different regions.
The key players are adopting various key strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the Tumor Necrosis Factor Inhibitor Drugs market globally. For instance, on July 27, 2021, AbbVie and Calico extended a collaboration focused on aging and age-related diseases. Also, in April 2021, Pfizer acquired Amplyx Pharmaceutical.
Company Name: DataM Intelligence
Contact Person: Sai
Email: Send Email
Phone: +1 877 441 4866
Country: United States